Table 2.

Quality indicators for endoscopic eradication therapy in Barrett’s esophagus

Quality Metric	Threshold Benchmark	Type of measure
The rate at which the reading is made by a GI pathologist or confirmed by a second pathologist before EET is begun for patients in whom a diagnosis of dysplasia is made	90%	Process
Centers in which EET is performed should have available HD-WLE and expertise in mucosal ablation and EMR techniques	--	Process
The rate at which documentation of a discussion of the risks, benefits, and alternatives to EET is obtained from the patient prior to treatment	>98%	Process
The rate at which landmarks and length of BE is documented (eg, Prague grading system) in patients with BE before EET	90%	Process
The rate at which the presence or absence of visible lesions is reported in patients with BE referred for EET	90%	Process
The rate at which the BE segment is inspected by using HD-WLE	95%	Process
The rate at which complete endoscopic resection (en bloc resection or piecemeal) is performed in patients with BE with visible lesions	90%	Process
The rate at which a defined interval for subsequent EET is documented for patients undergoing EET who have not yet achieved CE-IM	90%	Process
The rate at which CE-N and CE-IM is achieved by 18 months in patients with BE-related dysplasia or intramucosal cancer referred for EET	80%, 70%	Outcome
The rate at which a recommendation is documented for endoscopic surveillance at a defined interval for patients who achieve CE-IM	90%	Process
The rate at which biopsies of any visible mucosal abnormalities are performed during endoscopic surveillance after EET	95%	Process
The rate at which an anti-reflux regimen is recommended for EET	90%	Process
The rate at which adverse events are being tracked and documented in individuals after EET	90%	Process

Quality Indicators apply to pre-procedure (blue), intra-procedure (yellow), and post-procedure (green). GI, gastrointestinal; EET, endoscopic eradication therapy; HD-WLE, high-definition white light endoscopy; BE, Barrett’s esophagus; EMR, endoscopic mucosal resection; CE-IM, complete eradication of intestinal metaplasia; CE-N, complete eradication of neoplasia

^*Adapted from Wani et al (36)